LifeStance Health (LFST) Invested Capital (2020 - 2026)

LifeStance Health (LFST) has 7 years of Invested Capital data on file, last reported at $1.5 billion in Q1 2026.

• Quarterly Invested Capital rose 1.39% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 1.39% YoY) and the FY2025 annual result came in at $1.5 billion, up 5.17% from the prior year.
• Invested Capital slipped to $1.5 billion in Q1 2026 per LFST's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Invested Capital topped out at $1.6 billion in Q1 2022 and bottomed at $1.4 billion in Q1 2024.
• The 5-year median for Invested Capital is $1.5 billion (2026), against an average of $1.5 billion.
• The widest annual swing landed in 2022, when Invested Capital surged 63.1%; it then decreased 6.35% in 2023.
• Tracing LFST's Invested Capital over 5 years: stood at $1.5 billion in 2022, then dropped by 6.35% to $1.4 billion in 2023, then gained by 0.64% to $1.4 billion in 2024, then grew by 5.17% to $1.5 billion in 2025, then slipped by 2.87% to $1.5 billion in 2026.
• Per Business Quant, the three latest LFST Invested Capital figures stand at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025).

Peer Comparison